Patents
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2012
10/09/2012CA2458806C Antisense oligonucleotide against human ache and uses thereof
10/09/2012CA2403501C Non-invasive gene targeting to the brain
10/09/2012CA2323751C Diagnostics and vaccines for mycobacterial infections of animals and humans
10/09/2012CA2243845C Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity
10/09/2012CA2229204C Deubiquitinating enzymes that regulate cell growth
10/04/2012WO2012135868A2 Compositions and methods for the treatment and prevention of cardiac ischemic injury
10/04/2012WO2012135848A2 Melatonin-based treatment and diagnosis of bile duct disease
10/04/2012WO2012135820A2 Edible transgenic plants as oral delivery vehicles for rna-based therapeutics
10/04/2012WO2012135818A2 Cancer diagnostics, therapeutics, and drug discovery associated with macropinocytosis
10/04/2012WO2012135637A2 Inhibition of macrophage-synthesized wnt7b to inhibit tumor angiogenesis and metastasis
10/04/2012WO2012135592A2 Theranostic imaging agents and methods of use
10/04/2012WO2012135246A2 Compositions and methods for inhibiting expression of tmprss6 gene
10/04/2012WO2012135230A2 Compositions and methods to modulate hair growth
10/04/2012WO2012135081A2 Lin28-mediated control of let-7 biogenesis
10/04/2012WO2012134478A1 Compositions and methods for the treatment and prevention of cardiac ischemic injury
10/04/2012WO2012134234A2 Use of hades as a negative modulator of akt
10/04/2012WO2012134135A2 Spermine copolymer and gene therapy using the spermine copolymer as a nucleic-acid carrier
10/04/2012WO2012133997A1 Polysorbitol-based osmotically active transporter and gene therapy using same
10/04/2012WO2012133674A1 Method for removing tumorigenesis-causing cells among stem cells
10/04/2012WO2012132369A1 Viral vector targeting cancer stem cells
10/04/2012WO2012132141A1 Composition for delivering drug into cell and method therefor
10/04/2012WO2012131673A2 Ccat-1 silencing nucleic acid agents for treating cancer
10/04/2012WO2012130165A1 Liver cancer diagnosis marker and use thereof
10/04/2012WO2012129648A1 Enhancing protein expression of adeno-associated virus vectors
10/04/2012WO2012100172A3 Methods and compositions for the specific inhibition of hif-1a by double stranded rna
10/04/2012WO2012094495A3 Clip modulation for the treatment of mucosal diseases
10/04/2012WO2012092049A3 Brown adipocyte modification
10/04/2012WO2012071238A3 Treatment of nanog related diseases by inhibition of natural antisense transcript to nanog
10/04/2012WO2012006169A3 Compositions and methods for enhancement of nucleic acid delivery
10/04/2012US20120253020 Compositions and Methods for Identifying Agents Which Modulate PTEN Function and PI-3 Kinase Pathways
10/04/2012US20120252884 Modified and Stabilized GDF Propeptides and Uses Thereof
10/04/2012US20120252882 Cardiac-specific nucleic acid regulatory elements and methods and use thereof
10/04/2012US20120252880 Oligonucleotide Complex Compositions And Methods Of Use As Gene Alteration Tools
10/04/2012US20120252877 Methods and compositions for treatment of tuberous sclerosis complex
10/04/2012US20120252732 Albumin fusion proteins
10/04/2012US20120252726 Novel neurotrophic factors
10/04/2012US20120252114 Use of triplex structure dna in transferring nucleotide sequences
10/04/2012US20120252113 Use of triplex structure dna in transferring nucleotide sequences
10/04/2012US20120252097 Therapeutic Agents Comprising Pro-Apoptotic Proteins
10/04/2012US20120251620 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
10/04/2012US20120251543 Methods and compositions for modulating apoptosis
10/04/2012US20120251520 Ace2 activation for treatment of heart, lung and kidney disease and hypertension
10/04/2012US20120251498 Gene Delivery to Organs
10/04/2012US20120251457 Methods and compositions for modulating adipocyte function
10/04/2012CA2832151A1 Methods and compositions for treating brain diseases
10/04/2012CA2831613A1 Delivery and formulation of engineered nucleic acids
10/03/2012EP2505212A2 Novel P falciparum vaccine proteins and coding sequences
10/03/2012EP2504014A1 Modulation of epidermal growth factor receptor ligands
10/03/2012CN1993463B Follistatin mutant polypeptide
10/03/2012CN102712931A Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
10/03/2012CN102712927A Treatment of membrane bound transcription factor peptidase, site 1 (MBTPS1) related diseases by inhibition of natural antisense transcript to MBTPS1
10/03/2012CN102712925A Treatment of SIRTUIN (SIRT) related diseases by inhibition of natural antisense transcript to a SIRTUIN (SIRT)
10/03/2012CN102711812A Vaccine for treatment of tautopathy
10/03/2012CN102711799A Compositions and methods for wound treatment
10/03/2012CN102711777A Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood
10/03/2012CN102711756A Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability
10/03/2012CN102703508A Targeted GSK3beta (glycogen synthesis kinase 3beta) gene RNA interference recombinant slow virus carriers and constructing, screening methods thereof
10/03/2012CN102703507A shRNA lentiviral expression vector for specifically inhibiting hepatic cell CYP2E1 gene expression, constructing method and application thereof
10/03/2012CN102703505A Co-expressed brucella recombinant adenovirus as well as preparation method and use thererof
10/03/2012CN102703456A Action target site of death-associated protein kinase (DAPK3) gene hsa-miR-20a
10/03/2012CN102703452A siRNA double-strand for inhibiting Bcl2 gene expression and application thereof
10/03/2012CN102703447A Oligonucleotide with breast cancer treatment effect
10/03/2012CN102703393A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
10/03/2012CN102703389A Poxviral oncolytic vectors
10/03/2012CN102703380A Sub-totipotent stem cell, preparation method and application thereof
10/03/2012CN102703379A Human liver progenitors
10/03/2012CN102702358A Antibody against the CSF-1 R
10/03/2012CN102702319A HLA-A*3303-restricted wt1 peptide and pharmaceutical composition comprising the same
10/03/2012CN102701147A Method for preparing protein ribonuclease modified copper sulfide nanometer material
10/03/2012CN102698291A Brucella antigen gene combination ROB capable of improving cellullar immunologic response
10/03/2012CN102698290A Gene transfection method based on polyamide arborescent macromolecule carrier
10/03/2012CN102698289A Application of PABP inhibitor in preparation of medicament for resisting porcine reproductive and respiratory syndrome virus
10/03/2012CN102698288A Bacterially-delivered non-injective DNA vaccine
10/03/2012CN102698287A Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
10/03/2012CN102698279A Preparation method of amphipathic gama-polyglutanmic acid nanodrug carrier
10/03/2012CN102697732A Preparation method of gene and hydrophobic drug co-supported PEG (polyethyleneglycol) nanoparticles
10/03/2012CN102337264B siRNA sequence for inhibiting capripoxvirus P32 gene in targeted way and application of siRNA
10/03/2012CN102266561B Application of Wnt/beta-catenin signal channel inhibitor to preparation of medicament for promoting apoptosis
10/03/2012CN102154293B Small-interfering RNA (siRNA) capable of inhibiting classical swine fever virus (CSFV) reproduction and infection as well as preparation method and application thereof
10/03/2012CN102146412B Small molecular non-coding RNA gene hsa-miR-29b and use thereof
10/03/2012CN101812473B Human papillomavirus and chlamydia trachomatis chimeric nucleic acid vaccine and applications thereof
10/03/2012CN101792763B Antisense oligonucleotide for specifically adjusting POKEMON gene expression and application thereof
10/03/2012CN101698848B Goldfish autonomous transposon gene gfTol2, transposase coded by gene, and use of gene
10/03/2012CN101400368B Cancer treatment using viruses, fluoropyrimidines and camptothecins
10/03/2012CN101358200B RNA interference expression plasmid- cationic liposome-heparin antineoplastic complexes targeting human FAK and PLK1 gene
10/03/2012CN101067135B Novel oligonucleotides and use of oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments, as depigmentation agents
10/02/2012US8278428 Mitochondrial nucleic acid delivery systems
10/02/2012US8278422 Antibodies that specifically bind beta-like glycoprotein hormone polypeptides and heterodimers thereof
10/02/2012US8278286 Use of gp130 activators in diabetic neuropathy
10/02/2012US8278284 Therapeutic agents for diseases associated with apoptotic degeneration in ocular tissue cells that use SIV-PEDF vectors
10/02/2012US8278103 Oligonucleotides comprising alternating segments and uses thereof
10/02/2012US8278098 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
10/02/2012US8277846 Complexing agents for compositions containing inclusion complexes
10/02/2012US8277818 Herpes virus strains for gene therapy
10/02/2012US8277802 Diagnosis and prevention of cancer cell invasion
10/02/2012CA2530038C Vaccines comprising polynucleotides
10/02/2012CA2467215C Emulsion compositions
10/02/2012CA2402268C Immunostimulatory polynucleotide sequences for use in preventing and treating respiratory viral infections
10/02/2012CA2311297C Erythrovirus and its applications
10/02/2012CA2133306C Amplification of human mdm2 gene in human tumors
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 870